
Opinion: Measles almost killed me. Now I’m a doctor — and I’m scared of what’s happening
Jewel Mullen was in kindergarten in 1961 when she almost died from measles. Now a physician, measles’ return frightens her.
148 stories found

Jewel Mullen was in kindergarten in 1961 when she almost died from measles. Now a physician, measles’ return frightens her.

President Trump and his aides boasted that every U.S. state wanted to participate in a drug pricing initiative through Medicaid. Several states said they weren't sure yet.

Congress is considering linking doctor payment rates to medical inflation under the proposed Patients First Act.

What to know about Dr. Heidi Overton, Trump's pick to run the FDA, including her medical background and career trajectory.

A planned EO that would have greatly enhanced White House influence over grants at the NIH is “looking dead,” a source said.

Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.

Biotech investment firm Flagship Pioneering has been awarded a contract by the Department of Defense to advance countermeasure technologies against biological threats.

In this edition of STAT's AI Prognosis newsletter: Brittany Trang offers a few stories to make sense of the AI doom/slowdown talk, and more.

As of next month, a loophole that allows Americans to personally import their medications by mail is closing

The chilling effect of the Trump administration's dogged offensive against transgender health care has been swift, with dozens of hospitals across the U.S. ending care, even if they haven't been…

Other private equity-owned hospital chains have collapsed in recent years, so the stakes are high for Quorum.

“The maternal mental health needs of women like me have been badly underprioritized in American society,” writes Meg LeDuc.

Medicines for osteoporosis are grabbing the attention of the pharma industry, which has been incentivized by a long-awaited regulatory change.

Some health insurers push back on a Medicare proposal that would disrupt how doctors can bill for remotely monitoring patients' health.

For the second time this year, HHS announced new strategies to speed the away from animals in medical testing.

The White House's GENEROUS plan was designed to make drugs more affordable for Medicaid users. There's one glaring potential exception.

Eli Lilly and Novo Nordisk were already benefitting a great deal from the Trump administration's pilot program covering obesity drugs for seniors at a price of $245 a month. It…

In this edition of STAT Health Tech: What Epic's mortality prediction algorithm tells us about AI in geriatrics, Omada's expansion plans, and more.

Western pharmaceutical companies are urging the Trump administration to allow them to keep doing deals with Chinese companies for drug candidates

RFK Jr. has installed John Gaitanis, a pediatric neurologist, as the new chair of the Interagency Autism Coordinating Committee, which helps the federal government decide how to allocate roughly $2 billion…